These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30155922)

  • 1. Role of late amniocentesis in the era of modern genomic technologies.
    Daum H; Ben David A; Nadjari M; Zenvirt S; Helman S; Yanai N; Meiner V; Yagel S; Frumkin A; Shkedi Rafid S;
    Ultrasound Obstet Gynecol; 2019 May; 53(5):676-685. PubMed ID: 30155922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of late amniocentesis: a retrospective study in a tertiary fetal medicine center in China.
    Li Y; Yan H; Chen J; Chen F; Jian W; Wang J; Ye X; Li Y; Li N; Chiu PCN; Chen M
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):266. PubMed ID: 33784964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
    Lostchuck E; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic analysis in fetuses with late onset abnormal sonographic findings.
    Bardin R; Hadar E; Haizler-Cohen L; Gabbay-Benziv R; Meizner I; Kahana S; Yeshaya J; Yacobson S; Cohen-Vig L; Agmon-Fishman I; Basel-Vanagaite L; Maya I
    J Perinat Med; 2018 Nov; 46(9):975-982. PubMed ID: 28915119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit versus risk of chromosomal microarray analysis performed in pregnancies with normal and positive prenatal screening results: A retrospective study.
    Moshonov R; Hod K; Azaria B; Abadi-Korek I; Berger R; Shohat M
    PLoS One; 2021; 16(4):e0250734. PubMed ID: 33901244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of chromosomal microarray analysis over conventional karyotyping in stillbirth work-up: systematic review and meta-analysis.
    Martinez-Portilla RJ; Pauta M; Hawkins-Villarreal A; Rial-Crestelo M; Paz Y Miño F; Madrigal I; Figueras F; Borrell A
    Ultrasound Obstet Gynecol; 2019 May; 53(5):590-597. PubMed ID: 30549343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal abnormalities detected by karyotyping and microarray analysis in twins with structural anomalies.
    Li L; He Z; Huang X; Lin S; Wu J; Huang L; Wan Y; Fang Q
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):502-509. PubMed ID: 30977228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program.
    Vogel I; Petersen OB; Christensen R; Hyett J; Lou S; Vestergaard EM
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):480-486. PubMed ID: 28608362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnostic Yield of Chromosomal Microarray Analysis in Third-Trimester Fetal Abnormalities.
    Elron E; Maya I; Shefer-Averbuch N; Kahana S; Matar R; Klein K; Agmon-Fishman I; Gurevitch M; Basel-Salmon L; Levy M
    Am J Perinatol; 2024 Dec; 41(16):2232-2242. PubMed ID: 38688298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal microarray analysis in fetuses with aberrant right subclavian artery.
    Maya I; Kahana S; Yeshaya J; Tenne T; Yacobson S; Agmon-Fishman I; Cohen-Vig L; Levi A; Reinstein E; Basel-Vanagaite L; Sharony R
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):337-341. PubMed ID: 27063194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the application with the combination of CMA and karyotype in routine and late amniocentesis.
    Zheng Y; Zhong Z; Zhao Y; Zhang J; Yang L; Zhao J
    Arch Gynecol Obstet; 2024 Sep; 310(3):1555-1562. PubMed ID: 38955819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of chromosomal microarray in anomalous fetuses.
    Parchem JG; Sparks TN; Gosnell K; Norton ME
    Prenat Diagn; 2018 Jan; 38(2):140-147. PubMed ID: 29297200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis.
    Maya I; Yacobson S; Kahana S; Yeshaya J; Tenne T; Agmon-Fishman I; Cohen-Vig L; Shohat M; Basel-Vanagaite L; Sharony R
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):332-335. PubMed ID: 28133835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of chromosomal abnormalities in fetuses with abnormal cardiac ultrasound findings: evaluation of chromosomal microarray-based analysis.
    Mademont-Soler I; Morales C; Soler A; Martínez-Crespo JM; Shen Y; Margarit E; Clusellas N; Obón M; Wu BL; Sánchez A
    Ultrasound Obstet Gynecol; 2013 Apr; 41(4):375-82. PubMed ID: 23233332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniocentesis in pregnancies at or beyond 24 weeks: an international multicenter study.
    Zemet R; Maktabi MA; Tinfow A; Giordano JL; Heisler TM; Yan Q; Plaschkes R; Stokes J; Walsh JM; Corcoran S; Schindewolf E; Miller K; Talati AN; Miller KA; Blakemore K; Swanson K; Ramm J; Bedei I; Sparks TN; Jelin AC; Vora NL; Gebb JS; Crosby DA; Berkenstadt M; Weisz B; Wapner RJ; Van Den Veyver IB
    Am J Obstet Gynecol; 2024 Jun; ():. PubMed ID: 38914189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the third trimester amniocentesis for fetal karyotyping in women with fear of pregnancy loss].
    Picone O; Fuchs F; Sénat MV; Brisset S; Tachdjian G; Audibert F; Fernandez H; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):385-91. PubMed ID: 18191913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-nucleotide polymorphism-based chromosomal microarray analysis provides clues and insights into disease mechanisms.
    Daum H; Meiner V; Hacohen N; Zvi N; Eilat A; Drai-Hasid R; Yagel S; Zenvirt S; Frumkin A
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):655-660. PubMed ID: 30693591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome after third trimester amniocentesis: a single center experience.
    Gabbay-Benziv R; Yogev Y; Melamed N; Ben-Haroush A; Meizner I; Pardo J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):666-8. PubMed ID: 21834751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of expanded non-invasive prenatal screening and chromosomal microarray analysis in high-risk pregnancy.
    Zhu X; Chen M; Wang H; Guo Y; Chau MHK; Yan H; Cao Y; Kwok YKY; Chen J; Hui ASY; Zhang R; Meng Z; Zhu Y; Leung TY; Xiong L; Kong X; Choy KW
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):459-465. PubMed ID: 32198896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.